Practical patch testing and chemical allergens in contact dermatitis

Practical Patch Testing and Chemical Allergens in Contact Dermatitis

Volumn , Issue , 2013, Pages 1-132

  Jacob, Sharon E ^a   Herro, Elise M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899059203     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-4585-1     Document Type: Book

References (294)

1. Fisher AA. Contact dermatitis. Philadelphia: LEA and Febiger; 1967. p. 5.
2. Fernández Vozmediano JM, Armario Hita JC. Allergic contact dermatitis in children. J Eur Acad Dermatol Venereol. 2005;19(1):42-6.
3. Fisher AA. Childhood allergic contact dermatitis. Cutis. 1975;15:635.
4. Mark BJ, Slavin RG. Allergic contact dermatitis. Med Clin North Am. 2006;90(1):169-85.
5. Zug KA, McGinley-Smith D, Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children -a United States based study. Pediatr Dermatol. 2008;25(5):520.
6. der de Waard-van Spek FB, Oranje AP. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature. Dermatology. 2009;218(2):119-25.
7. Jacob SE, Steele T. Contact dermatitis and workforce economics. Semin Cutan Med Surg. 2006;25(2):105-9.
8. American Contact Dermatitis Society. Updated 2009. http://www. contactderm.org/files/members/CoreSeries10-27-09.pdf Accessed June 2012.
9. Perfumes, Flavors. allergEAZE allergens. Updated June 2012. http:// www.allergeaze.com/allergens.aspx?ID=PF Accessed May 2012.
10. Cosmetic Grouping. allergEAZE allergens. Updated June 2012. http://www.allergeaze.com/allergens.aspx?ID=Cosmetic Accessed May 2012.
11. Dental Materials. allergEAZE allergens. Updated June 2012. http:// www.allergeaze.com/allergens.aspx?ID=DM Accessed May 2012.
12. Bakery Series. Chemotechnique diagnostics, p. 32-3. 2012. http://www. chemotechnique.se/Online-Catalogue.htm Accessed June 2012.
13. Riemann H, Schwarz T, Grabbe S. Pathomechanisms of the elicitation phase of allergic contact dermatitis. J Dtsch Dermatol Ges. 2003;1(8):613-9.
14. Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Science Publishing; 2005.
15. Nijhawen RI, Matiz C, Jacob SE. Contact dermatitis: from basics to allergodromes. Pediatr Ann. 2009;38(2):99-108.
16. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18:385-90.
17. Elsaie ML, Olasz E, Jacob SE. Cytokines and langerhans cells in allergic contact dermatitis. G Ital Dermatol Venereol. 2008;143(3): 195-205.
18. Jacob SE, Breithaupt A. Environmental exposures -a pediatric perspective on allergic contact dermatitis. Skin Aging. 2009;17(7): 28-36.
19. Zug KA, McGinley-Smith D, Warshaw EM, Taylor JS, Rietschel RL, Maibach HI, Belsito DV, Fowler Jr JF, Storrs FJ, DeLeo VA, Marks Jr JG, Mathias CG, Pratt MD, Sasseville D. Contact allergy in children referred for patch testing North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol. 2008;144(10):1329-36.
20. Hogeling M, Pratt M. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006. Dermatitis. 2008;19(2):86-9.
21. Hsu J, Jacob SE. The other side of athletic safety gear in adolescents: the role of p-tert-butylphenol-formaldehyde-resin in allergic contact dermatitis. J Dermatol Nurs. 2009;1(3):198-200.
22. Vincenzi C, Guerra I, Peluso AM, Zucchelli V. Allergic contact dermatitis due to phenol-formaldehyde resin in a knee-guard. Contact Dermatitis. 1992;27(1):54.
23. Sommer S, Wilkinson SM, Dodman B. Contact dermatitis due to urea-formaldehyde resin in shin-pads. Contact Dermatitis. 1999;40(3): 159-60.
24. Shono M, Ezoe K, Kaniwa M, et al. Allergic contact dermatitis from para -tertiary-butylphenol formaldehyde resin (PTBP-FR) in athletic tape and leather adhesive. Contact Dermatitis. 1991;24(4):281-8.
25. Azurdia RM, King CM. Allergic contact dermatitis due to phenolformaldehyde resin and benzoyl peroxide in swimming goggles. Contact Dermatitis. 1998;38(4):234-5.
26. Herro EM, Jacob SE. Product allergen watch: p-tert-butylphenol formaldehyde resin and the impact on children. Dermatitis. 2012; 23(2):86-8.
27. Rietschel RL, Fowler JF, editors. Fisher's contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
28. Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroidspearing agent to consider in children. Pediatr Dermatol. 2008; 25(1):81-7.
29. Jacob SE, Stechschulte SA. Tosylamide/formaldehyde resin allergy -a consideration in the atopic toddler. Contact Dermatitis. 2008; 58(5):312-3.
30. Jacob SE, Steele T, Brod B, Crawford GH. Dispelling the myths behind pediatric patch testing -experience from our tertiary care patch testing centers. Pediatr Dermatol. 2008;25(3):296-300.
31. Mydlarski PR, Katz AM, Mamelak AJ, et al. Contact dermatitis. In: Adkinson NF, Yunginger JW, Busse WW, editors. Middleton's allergy principles and practice. Philadelphia: Mosby; 2003. p. 1581-93.
32. Friedlander SF. Consultation with the specialist: contact dermatitis. Pediatr Rev. 1998;19(5):166-71.
33. Amaro C, Goossens A. Immunological occupational contact urticaria and contact dermatitis from proteins: a review. Contact Dermatitis. 2008;58:67-75.
34. Hjorth N, Roed-Peterson J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28-42.
35. Janssens V, Morren M, Dooms-Goossens A, Degreef H. Protein contact dermatitis: myth or reality? Br J Dermatol. 1995;132:1-6.
36. Jacob SE, Herro EM, Taylor JS. Contact dermatitis: diagnosis and therapy. In: Elzouki AY, editor. Textbook of clinical pediatrics, vol. 3, Section 9. 2nd ed. Berlin, Heidelberg: Springer; 2012. p. 1467-76.
37. Nijhawan RI, Jacob SE. Patch testing: the whole in addition to the sum of its parts is greatest. Dermatitis. 2009;20(1):58-9.
38. Worm M, Aberer W, Agathos M, Becker D, Brasch J, Fuchs T, Hillen U, Hoger P, Mahler V, Schnuch A, Szliska C. Patch testing in children -recommendations of the German Contact Dermatitis Research Group (DKG). J Dtsch Dermatol Ges. 2007;5:107-9.
39. Matiz C, Russell K, Jacob SE. The importance of checking for delayed reactions in pediatric patch testing. Pediatr Dermatol. 2011;28(1):12-4.
40. Jensen CD, Paulsen E, Andersen KE. Retrospective evaluation of the consequence of alleged patch test sensitization. Contact Dermatitis. 2006;55(1):30-5.
41. Bygum A, Andersen KE. Persistent reactions after patch testing with TRUE test panels 1 and 2. Contact Dermatitis. 1998;38:218-20.
42. Wilkinson SM, Pollock B. Patch test sensitization after use of the compositae mix. Contact Dermatitis. 1999;40:277-8.
43. Devos SA, Van Der Valk PG. The risk of active sensitization to PPD. Contact Dermatitis. 2001;44:273-5.
44. Barros MA, Baptista A, Correia TM, et al. Patch testing in children: a study of 562 school children. Contact Dermatitis. 1991;25:156-9.
45. ACDS CAMP. American Contact Dermatitis Society. 2011. http:// www.contactderm.org/i4a/pages/index.cfm?pageid=3489 Accessed 24 Mar 2011.
46. CARD: Contact Allergen Replacement Database. 2011. http://www. preventice.com/card/ Accessed 24 Mar 2011.
47. Jacob SE, Castanedo-Tardan MP. Pharmacotherapy for allergic contact dermatitis. Expert Opin Pharmacother. 2007;8(16): 2757-74.
48. Scheman A, Jacob S, Zirwas M, Warshaw E, Nedorost S, Katta R, Cook J, Castanedo-Tardan MP. Contact allergy: alternatives for the 2007 North American Contact Dermatitis Group (NACDG) standard screening tray. Dis Mon. 2008;54(1-2):7-156.
49. Scheman A, Jacob S, Katta R, Nedorost S, Warshaw E, Zirwas M, Cha C. Part 1 of a 4-part series facial cosmetics: trends and alternatives: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol. 2011;4(6):25-30.
50. Scheman A, Jacob S, Kaita R, Nedorost S, Warshaw E, Zirwas M, Bhinder M. Part 2 of a 4-part series hair products: trends and alternatives: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol. 2011;4(7):42-6.
51. Scheman A, Jacob S, Katta R, Nedorost S, Warshaw E, Zirwas M, Kruk A. Part 3 of a 4-part series Lip and common dental care products: trends and alternatives: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol. 2011;4(9):50-3.
52. Scheman A, Jacob S, Katta R, Nedorost S, Warshaw E, Zirwas M, Selbo N. Part 4 of a 4-part series miscellaneous products: trends and alternatives in deodorants, antiperspirants, sunblocks, shaving products, powders, and wipes: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol. 2011;4(10):35-9.
53. Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther. 2004;17:334-40.
54. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1-15; quiz 6-8.
55. Marks R. Adverse side effects from the use of topical corticosteroids. In: Maibach HI, Surger C, editors. Topical corticosteroids. Basel: Karger; 1992. p. 170-83.
56. Belsito D, Wilson DC, Warshaw E, Fowler J, Ehrlich A, Anderson B, et al. A prospective randomized clinical trial of 0.1 % tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55:40-6.
57. Wollina U. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol. 2007;8(3):157-73.
58. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25:559-66.
59. Zirwas MJ. Acrylates. Dermatitis. 2006;17(2):109-10.
60. Bjorkner B. Plastic materials. In: Adams RM, editor. Occupational skin disease. Philadelphia: WB Saunders; 1999. p. 434-64.
61. Bjorkner B. Acrylic resins. In: Kanerva I, Elsner P, Wahberg JE, Maibach HI, editors. Handbook of occupational dermatology. Berlin: Springer; 2000. p. 562-9.
62. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis. 2004;15:176-83.
63. Cronin H, Mowad C. Anaphylactic reaction to bacitracin ointment. Cutis. 2009;83(3):127.
64. Herro EM, Jacob SE. Allergen focus: allergic contact cheilitis. Skin Aging. 2011;19(8):18-22.
65. Jacob SE, Herro EM. Allergen focus: fragrances and flavorants. Skin Aging. 2011;19(7):23-8.
66. Chatard H. Sensitization to perfumes with skin & general reactions. Lyon Med. 1957;89(36):212-3.
67. Hjorth N. Eczematous allergy to balsams, allied perfumes and flavouring agents, with special reference to balsam of Peru. Acta Derm Venereol Suppl (Stockh). 1961;41 Suppl 46:1-216.
68. Tomar J, Jain VK, Aggarwal K, Dayal S, Gupta S. Contact allergies to cosmetics: testing with 52 cosmetic ingredients and personal products. J Dermatol. 2005;32:951-5.
69. Fisher AA. Cosmetic dermatitis in childhood. Cutis. 1995;55:15-6.
70. Salam TN, Fowler JF. Balsam-related systemic contact dermatitis. J Am Acad Dermatol. 2001;45(3):377-81.
71. Srivastava D, Cohen DE. Identification of the constituents of balsam of Peru in tomatoes. Dermatitis. 2009;20(2):99-105.
72. Magnusson B, Wilkinson DS. Cinnamic aldehyde in toothpaste. Contact Dermatitis. 1975;1:70-6.
73. Strauss RM, Orton DI. Allergic contact cheilitis in the United Kingdom: a retrospective study. Am J Contact Dermat. 2003;14:75-7.
74. Veien NK, Hattel T, Justesen O, Nørholm N. Oral challenge with balsam of Peru. Contact Dermatitis. 1985;12(2):104-7.
75. Scheinman PL. Allergic contact dermatitis to fragrance: a review. Am J Contact Dermat. 1996;7(2):65-76.
76. Herro EM, Jacob SE. Diaper dermatitis. In: Heymann WR, et al., editors. Clinical decision support: dermatology. Anticipated Publication; Fall 2012. Online publication: Copyright © 2013, Decision Support in Medicine, LLC. http://www.decisionsupportinmedicine.com/.
77. de Groot AC, Frosch PJ. Adverse reactions to fragrances. A clinical review. Contact Dermatitis. 1997;36(2):57-86.
78. Belsito DV. Surviving on a balsam-restricted diet: cruel and unusual punishment or medically necessary therapy? J Am Acad Dermatol. 2001;45(3):470-1.
79. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 176, 417-8, 714.
80. Stanford D, Georgouras K. Allergic contact dermatitis from benzalkonium chloride in plaster of Paris. Contact Dermatitis. 1996;35(6):371-2.
81. Staniforth P. Allergy to benzalkonium chloride in plaster of Paris after sensitisation to cetrimide. A case report. J Bone Joint Surg Br. 1980;62-B(4):500-1.
82. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 279.
83. Le Coz CJ, Bottlaender A, Scrivener JN, Santinelli F, Cribier BJ, Heid E, Grosshans EM. Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis. 1998;38(5):245-52.
84. Jacob SE. 2006. Focus on T.R.U.E. test allergen #19 mercaptobenzothiazole & #22 mercapto mix. Skin Aging. 2006;14(9).
85. Menne T, White IR, Bruynzeel DP, Dooms-Goossens A. Patch test reactivity to the PPD-black rubber mix (industrial rubber chemicals) and individual ingredients. Contact Dermatitis. 1992; 26(5):354.
86. Jacob SE, Caperton CV. Focus on T.R.U.E. test allergen #16: black rubber mix. Skin Aging. 2006;13(6):20-4.
87. Schwartz L, Tulipan L, Birmingham DJ. Dermatoses in the manufacture of rubber. In: Occupational diseases of the skin. Philadelphia: Lea & Febiger; 1957.
88. Warshaw E. Latex allergy. Skinmed. 2003;2(6):359-66.
89. Conde-Salazar L, Del Rio E, Guimaraens D, Gonzalez Domingo A. Type IV allergy to rubber additives: a 10 year study of 686 cases. J Am Acad Dermatol. 1993;29:176-80.
90. Anderson ME, Kirkland KH, Guidotti TL, Rose C. A case study of tire crumb use on playgrounds: risk analysis and communication when major clinical knowledge gaps exist. Environ Health Perspect. 2006;114(1):1-3.
91. Weinberger LN, Seraly MP, Zirwas MJ. Palmar dermatitis due to a rubber escalator railing. Contact Dermatitis. 2006;54:59.
92. Nethercott JR, et al. Patch testing with a routine screening tray in North America, 1985-1989: gender and response. Am J Contact Dermat. 1991;2:130.
93. Jacob SE, Patel A. Focus on T.R.U.E. test allergen #5: caines. Skin Aging. 2005;13(7):22-4.
94. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 288-95.
95. Carazo JL, Morera BS, Colom LP, Gálvez Lozano JM. Allergic contact dermatitis from ethyl chloride and benzocaine. Dermatitis. 2009;20(6):E13-5.
96. Rietschel RL, Fowler JF. Local anesthetics and topical analgesics. In: Fisher's contact dermatitis. 5th ed. New York: Lippincott Williams & Wilkins; 2001. p. 193-202.
97. Sidhu SK, Shaw S, Wilkinson JD. A 10-year retrospective study on benzocaine allergy in the United Kingdom. Am J Contact Dermat. 1999;10:57-61.
98. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 239-53.
99. Brant WT, editor. The metallic alloys: a practical guide for the manufacture of all kinds of alloys, amalgams, and solders, used by metalworkers: together with their chemical and physical properties and their application in the arts and the industries. London: Henry Cary Baird & Co.; 1896.
100. Marks Jr JG, Elsner P, DeLeo V. Standard allergens. In: Marks Jr JG, Elsner P, DeLeo V, editors. Contact and occupational dermatology. 3rd ed. St. Louis: Mosby; 2002. p. 65-139.
101. Veien NK, Hattel T, Justesen O, Nørholm A. Oral challenge with metal salts. (I). Vesicular patch-test-negative hand eczema. Contact Dermatitis. 1983;9:402-10.
102. Stuckert J, Nedorost S. Low-cobalt diet for dyshidrotic eczema patients. Contact Dermatitis. 2008;59(6):361-5.
103. Thyssen JP, Menné T, Johansen JD, Lidén C, Julander A, Møller P, Jellesen MS. A spot test for detection of cobalt release -early experience and findings. Contact Dermatitis. 2010;63(2):63-9.
104. EM Quant® cobalt test strips. Updated 2012. http://www.emdmillipore. com/chemicals/em-quant-cobalt-test-strips/EMD_CHEM-10002/p_JvSb.s1LxioAAAEWh.IfVhTl Accessed 15 July 2012.
105. Cobalt test strips 10-1000 ppm EM Quant. Updated 2012. http:// www.galladechem.com/catalog/emd_teststrips/cobalt-test-strips-10-1000-ppm-em-quant-1-pk-of-100.htm Accessed 15 July 2012.
106. Jacob SE, Yang A, Herro EM, Zhang C. Contact allergens in a pediatric population: association with atopic dermatitis and comparison with other North American referral centers. J Clin Aesthet Dermatol. 2010;3(10):29-35.
107. Jacob SE, Amini S. Focus on allergen of the year 2004: CAPB. Skin Aging. 2006;14(8):12-4.
108. Suuronen K, Pesonen M, Aalto-Korte K. Occupational contact allergy to cocamidopropyl betaine and its impurities. Contact Dermatitis. 2012;66(5):286-92.
109. de Groot AC, van der Walle HB, Weyland JW. Contact allergy to cocamidopropyl betaine. Contact Dermatitis. 1995;33:419-22.
110. Fowler JF, Fowler LM, Hunter JE. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study. Contact Dermatitis. 1997;37:276-81.
111. Fowler Jr JF, Zug KM, Taylor JS, Storrs FJ, Sherertz EA, Sasseville DA, et al. Allergy to cocamidopropyl betaine and amidoamine in North America. Dermatitis. 2004;15:5-6.
112. Foti C, Bonamonte D, Mascolo G, Corcelli A, Lobasso S, Rigano L, et al. The role of 3-dimethylaminopropylamine and amidoamine in contact allergy to cocamidopropylbetaine. Contact Dermatitis. 2003;48:194-8.
113. Angelini G, Foti C, Rigano L, Vena GA. 3-Dimethylaminopropylamine: a key substance in contact allergy to cocamidopropylbetaine? Contact Dermatitis. 1995;32:96-9.
114. Hunter JE, Fowler JF. Safety to human skin of cocamidopropyl betaine: a mild surfactant for personal-care products. J Surfact Deterg. 1998;1(2):235-9.
115. Jacob SE, Chimento S. Focus on T.R.U.E. test allergen #7: colophony. Skin Aging. 2005;13(9):25-8.
116. Wöhrl S, Hemmer W, Focke M, et al. The significance of fragrance mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy. Br J Dermatol. 2001;145:268-73.
117. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 419.
118. Jacob SE, Zapolinski T. Focus on: compositae. Skin Aging. 2007;15(6):44-7.
119. Mittra S, Datta A, Singh K, Singh A. 5-Hydroxytyptamine-inhibiting property of feverfew: role of parthenolide content. Acta Pharmacol Sin. 2000;21(12):1106-14.
120. Paulsen E, Andersen KE, Brandao FM, Bruynzeel DP, Ducombs G, Frosch PJ, Goossens A, Lahti A, Menne T, Shaw S, Tosti A, Wahlberg JE, Wilkinson JD, Wrangsjo K. Routine patch testing with the sesquiterpene lactone mix in Europe: a 2-year experience. A multicentre study of the EECDRG. Contact Dermatitis. 1999;40(2):72-6.
121. Orion E, Paulsen E, Andersen KE, Menne T. Comparison of simultaneous patch testing with parthenolide and sesquiterpene lactone mix. Contact Dermatitis. 1998;38:207-8.
122. Lundh K, Hindsen M, Gruvberger B, Moller H, Svensson A, Bruze M. Contact allergy to herbal teas derived from Asteraceae plants. Contact Dermatitis. 2006;54(4):196-201.
123. Rodriquez-Serna M, Sanchez-Motilla JM, Ramon R, Aliaga A. Allergic and systemic contact dermatitis from Matricaria chamomilla tea. Contact Dermatitis. 1998;39:192-209.
124. Mahajan VK, Sharma NL, Chander Sharma R. Parthenium dermatitis: is it a systemic contact dermatitis or an airborne contact dermatitis? Contact Dermatitis. 2004;51:231-4.
125. Hausen BM, Osmundsen PE. Contact allergy to parthenolide in Tanacetum parthenium (L.) schulz-Bip. (Feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species. Acta Derm Venereol. 1983;63(4):308-14.
126. Paulsen E, Andersen KE, Hausen BM. Sensitization and cross-reaction patterns in Danish Compositae-allergic patients. Contact Dermatitis. 2001;45(4):197-204.
127. Davis MD, El-Azhary RA, Farmer SA. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. J Am Acad Dermatol. 2007;56:921-7.
128. Coopman S, et al. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121:27-34.
129. Rycroft RJE et al., eds. Textbook of contact dermatitis. 3rd ed. Berlin: Springer; 2001.
130. Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross reactivity. J Am Acad Dermatol. 2006;54(4):723-7.
131. Jacob SE, Steele T. Focus on allergen of the year 2005: corticosteroids. Skin Aging. 2006;33-6.
132. Baeck M, Goossens A. New insights about delayed allergic hypersensitivity to corticosteroids. G Ital Dermatol Venereol. 2012;147(1):65-9.
133. Cohen DE, Brancaccio R. What is new in clinical research in contact dermatitis. Dermatol Clin. 1997;15:137-48.
134. Boffa MJ, Wilkinson SM, Beck HM. Screening for corticosteroid contact hypersensitivity. Contact Dermatitis. 1995;33:149-51.
135. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121:27-34.
136. Wilkinson SM. Corticosteroid cross-reactions: an alternative view. Contact Dermatitis. 2000;42:59-63.
137. Foti C, Bonifazi E, Casulli C, Bonamonte D, Conserva A, Angelini G. Contact allergy to topical corticosteroids in children with atopic dermatitis. Contact Dermatitis. 2005;52:162-3.
138. Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children -a United States based study. Pediatr Dermatol. 2008;25(5):520-7.
139. Mimesh S, Pratt M. Allergic contact dermatitis from corticosteroids: reproducibility of patch testing and correlation with intradermal testing. Dermatitis. 2006;17:137-42.
140. Isaksson M, Bruze M, Lepoittevin JP, Goossens A. Patch testing with serial dilutions of budesonide, its R and S diastereomers, and potentially cross-reacting substances. Am J Contact Dermat. 2001;12:170-6.
141. Bruze M, Zimerson E. Dimethyl fumarate. Dermatitis. 2011; 22(1):3-7.
142. Giménez-Arnau A. Dimethyl fumarate: a human health hazard. Dermatitis. 2011;22(1):47-9.
143. Stefanelli P, Barbini DA, Girolimetti S, Santilio A, Dommarco R. Determination of dimethyl fumarate (DMFu) in silica gel pouches using gas chromatography coupled ion trap mass spectrometry. J Environ Sci Health B. 2011;46(4):341-9.
144. Gennari O, Montesano D, Salzano A, Albrizio S, Grumetto L. Determination of dimethyl fumarate in desiccant and antimould sachets by reversed-phase liquid chromatography. Biomed Chromatogr. 2011;25(12):1315-8.
145. D'Erme AM, Bassi A, Lotti T, Gola M. Dimethyl fumarate contact dermatitis of the foot: an increasingly widespread disease. Int J Dermatol. 2012;51(1):42-5. doi: 10.1111/j.1365-4632.2011.04916.x.
146. Lo Balbo A, Gotelli MJ, Mac Cormack WP, Kogan N, Gotelli C. Contact dermatitis caused by dimethylfumarate in Argentina. Clin Toxicol (Phila). 2011;49(6):508-9.
147. Silvestre JF, Toledo F, Mercader P, Giménez-Arnau AM. A summary of shoe allergic contact dermatitis caused by dimethyl fumarate in Spain. Contact Dermatitis. 2011;65(2):122-3.
148. Commission decision of 17 March 2009 requiring member states to ensure that products containing the biocide dimethyl fumarate are not placed or made available on the market. Off J Eur Union. 2009;52:32-4.
149. Lazarov A, Trattner A, David M, Ingber A. Textile dermatitis in Israel: a retrospective study. Am J Contact Dermat. 2000;11:26-9.
150. Pratt M, Taraska V. Disperse blue dyes 106 and 124 are common causes of textile dermatitis and should serve as screening allergens for this condition. Am J Contact Dermat. 2000;11:30-41.
151. Giusti F, Massone F, Bertoni L, Pellacani G, Seidenari S. Contact sensitization to disperse dyes in children. Pediatr Dermatol. 2003;20:393-7.
152. Alberta L, Sweeney SM, Wiss K. Diaper dye dermatitis. Pediatrics. 2005;116:e450-2.
153. Batchelor RJ, Wilkinson SM. Contact allergy to disperse dyes in plastic spectacle frames. Contact Dermatitis. 2006;54:66-7.
154. Guin JD. Seat-belt dermatitis from disperse blue dyes. Contact Dermatitis. 2001;44:263.
155. Jacob SE, Steele T. Focus on T.R.U.E. test allergen #14: epoxy. Skin Aging. 2006;18-20, 22.
156. Summerfield W, Goodson A, Cooper I. Survey of bisphenol a diglycidyl ether (BADGE) in canned foods. Food Addit Contam. 1998;15(7):818-30.
157. Jacob SE, Ballard CJ. Focus on T.R.U.E. test allergen #11: ethylenediamine. Skin Aging. 2006;19-22.
158. Lands AM, Hoppe JO. The toxicologic properties of N, N-dimethyl-N'-(3-thenyl)-N'-(2-pyridyl)ethylenediamine hydrochloride (thenfadil) a new antihistaminic drug. J Pharmacol Exp Ther. 1949;97(3):371-8.
159. Scheman AJ, Carroll PA, Brown KH, Osburn AH. Formaldehyderelated textile allergy: an update. Contact Dermatitis. 1998;38: 332-6.
160. Rietschel RL. Experience with supplemental allergens in the diagnosis of contact dermatitis. Contact Dermatitis. 2000;65:27-30.
161. Fowler Jr JF, Skinner SM, Belsito DV. Allergic contact dermatitis from formaldehyde resins in permanent press clothing: an underdiagnosed cause of generalized dermatitis. J Am Acad Dermatol. 1992;27:962-8.
162. DeGroot AC, Maibach HI. Does allergic contact dermatitis from formaldehyde in clothes treated with durable-press chemical finishes exist in the USA? Contact Dermatitis. 2010;62:127-36.
163. Trattner A, Johansen JD, Menné T. Formaldehyde concentration in diagnostic patch testing: comparison of 1 % with 2 %. Contact Dermatitis. 1998;38:9-13.
164. Jacob SE, Steele T, Rodriguez G. Focus on T.R.U.E. test allergens # 21, 13, and 18: formaldehyde, p-tert butylphenol formaldehyde resin and quaternium 15. Skin Aging. 2005; 22-5.
165. Moennich JN, Hanna DM, Jacob SE. Formaldehyde-releasing preservative in baby and cosmetic products: health risks related to exposure during infancy. J Dermatol Nurs. 2009;1(3):211-4.
166. Jacob SE, Steele T. Avoiding formaldehyde allergic reactions in children. Pediatr Ann. 2007;36(1):55-6.
167. Jordan Jr WP, Sherman WT, King SE. Threshold responses in formaldehyde-sensitive subjects. J Am Acad Dermatol. 1979;1: 44-8.
168. Russell K, Jacob SE. Sodium hydroxymethylglycinate. Dermatitis. 2010;21(2):109-10.
169. Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. Opinion concerning a clarification on the formaldehyde and para-formaldehyde entry in directive 76/768/ EEC on cosmetic products. SCCNFP/587/02, final. Adopted by the SCCNFP during the 22nd plenary meeting of 17 December 2002. http://ec.europa.eu/health/ph_risk/committees/sccp/documents/ out187_en.pdf Accessed 22 Mar 2011.
170. De Groot AC, White IR, Flyvholm M, Lensen G, Coenraads P. Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy: part 1. Characterization, frequency and relevance of sensitization, and frequency of use in cosmetics. Contact Dermatitis. 2010;62:2-17.
171. Herbert C, Rietschel RL. Formaldehyde and formaldehyde releasers: How much avoidance of cross-reacting agents is required? Contact Dermatitis. 2004;50(6):371-3.
172. Habeck M. Formaldehyde. 2010. [1 screen]. Eco-USA.net. http:// www.ecousa.net/toxics/chemicals/formaldehyde.shtml Accessed 22 Mar 2011.
173. Maier LE, Lampel HP, Bhutani T, Jacob SE. Hand dermatitis: a focus on allergic contact dermatitis to biocides. Dermatol Clin. 2009;27(3):251-64, v-vi.
174. Cook P, Sleeker C. Bakelite: an illustrated guide to collectible bakelite objects. Secaucus/ NewYork: Chartwell Books; 1992.
175. Restani P, Campagner P, Fiecchi A, et al. Identification of spinacine as the principal reaction product of gamma-casein with formaldehyde in cheese. Food Chem Toxicol. 1988;26(5):441-6.
176. Hill AM, Belsito DV. Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame. Contact Dermatitis. 2003;49(5):258-9.
177. Poliovirus Vaccine Inactivated IPOL. U.S. food and drug administration. screen. http://www.fda.gov/downloads/Biologics-BloodVaccines/Vaccines/ApprovedProducts/UCM133479.pdf Accessed 22 Mar 2011.
178. BioThrax® (Anthrax Vaccine Adsorbed). U.S. food and drug administration. 16 screens. http://www.fda.gov/downloads/Biologics-BloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/UCM074923.pdf Accessed 22 Mar 2011.
179. Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®. U.S. food and drug administration. 2005. 13 screens. http://www.fda.gov/downloads/Biologics-BloodVaccines/ Vaccines/ApprovedProducts/UCM101580.pdf Accessed 22 Mar 2011.
180. Havrix (Hepatitis A Vaccine). U.S. food and drug administration. screens. http://www.fda.gov/downloads/BiologicsBlood Vaccines/Vaccines/ApprovedProducts/UCM224555.pdf Accessed 22 Mar 2011.
181. Zug KA, Warshaw EM, Fowler JF, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009;20(3):149-60.
182. Herro EM, Elsaie ML, Nijhawan RI, Jacob SE. Comparison of allergens in allergic contact eyelid dermatitis -recommendations for a screening series. Dermatitis. 2012;23(1):17-20.
183. Jacob SE, Maldonado EA, Herro EM. Allergen focus: formaldehyde and formaldehyde releasing preservatives revisited. Skin Aging. 2011;19(6):24-7.
184. Bardana Jr EJ, Montanaro A. Formaldehyde: an analysis of its respiratory, cutaneous, and immunologic effects. Ann Allergy. 1991;66(6):441-52.
185. Agner T, Flyvholm MA, Menne T. Formaldehyde allergy: a followup study. Am J Contact Dermat. 1999;10:12-7.
186. Trocho C, Pardo R, Rafecas I, et al. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci. 1998;63(5):337-49.
187. Jacob SE, Stechschulte S. Formaldehyde, aspartame and migraines: a possible connection. Dermatitis. 2008;19(3):E10-1.
188. Fransway AF, Schmitz NA. The problem of preservation in the 1990s. II. Formaldehyde and formaldehyde releasing biocides: incidences of cross-reactivity and the significance of the positive response to formaldehyde. Am J Contact Dermat. 1991;2:78-88.
189. Baker RR. The generation of formaldehyde in cigarettes: overview and recent experiments. Food Chem Toxicol. 2006;44(11): 1799-822.
190. Andersen K, White I, Goossens A. Allergens from the standard series. In: Rycroft R, Menne T, Frosch P, Lepoittevin JP, editors. Textbook of contact dermatitis. 3rd ed. New York: Springer; 2001.
191. Sasseville D. Hypersensitivity to preservatives. Dermatol Ther. 2004;17(3):251-63.
192. Jacob SE, Hsu JW. Sodium hydroxymethylglycinate: a potential formaldehyde-releasing preservative in child products. Dermatitis. 2009;10(6):347-9.
193. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 268-9.
194. Warshaw EM, Ahmed RL, Belsito DV, et al. Contact dermatitis of the hands: cross-sectional analyses of North American contact dermatitis group data, 1994-2004. J Am Acad Dermatol. 2007;57:301-14.
195. Jacob SE, Amado A. Focus on T.R.U.E. test allergen #6: fragrance mix. Skin Aging. 2006;14(4):16-8, 22.
196. Chatard H. Case of sensitization to perfumes with cutaneous and general reactions. Bull Soc Fr Dermatol Syphiligr. 1957;64(3):323.
197. Larsen WG. Perfume dermatitis. A study of 20 patients. Arch Dermatol. 1977;113(5):623-6.
198. Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol. 2003;4(11):789-98.
199. Militello G, James W. Lyral: a fragrance allergen. Dermatitis. 2005;16(1):41-4.
200. Scheinman PL. The foul side of fragrance-free products: what every clinician should know about managing patients with fragrance allergy. J Am Acad Dermatol. 1999;41(6):1020-4.
201. Food and Drugs. Food and Drug Administration Department of Health and Human Services. Code of Federal Regulations. http:// www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch. cfm?CFRPart=700&showFR=1 Accessed 25 Jan 2006.
202. Jacob SE, Amado A. Focus on T.R.U.E. test allergen #10: balsam of Peru. Skin Aging. 2005;13(3):23-4.
203. Smith WJ, Jacob SE. The role of allergic contact dermatitis in diaper dermatitis. Pediatr Dermatol. 2009;26(3):369-70.
204. Patch Test Products 2011. Chemotechnique diagnostics. 2011. http:// www.chemotechnique.se/Catalogue.htm Accessed 28 Mar 2011.
205. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 552.
206. Warshaw EM, Schram SE, Maibach HI, Belsito DV, Marks Jr JG, Fowler Jr JF, Rietschel RL, Taylor JS, Mathias CG, DeLeo VA, Zug KA, Sasseville D, Storrs FJ, Pratt MD. Occupation-related contact dermatitis in North American health care workers referred for patch testing: cross-sectional data, 1998 to 2004. Dermatitis. 2008;19(5):261-74.
207. Shaffer MP, Belsito DV. Allergic contact dermatitis from glutaraldehyde in health-care workers. Contact Dermatitis. 2000;43(3):150-6. Review.
208. Ravis SM, Shaffer MP, Shaffer CL, Dehkhaghani S, Belsito DV. Glutaraldehyde-induced and formaldehyde-induced allergic contact dermatitis among dental hygienists and assistants. J Am Dent Assoc. 2003;134(8):1072-8.
209. Marks JG, DeLeo VA, editors. Contact and occupational dermatology. 2nd ed. St Louis: Mosby; 1997.
210. Rietschel RL, Warshaw EM, Sasseville D, Fowler JF, DeLeo VA, Belsito DV, Taylor JS, Storrs FJ, Mathias CG, Maibach HI, Marks JG, Zug KA, Pratt M, North American Contact Dermatitis Group. Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. Dermatitis. 2007;18(2):78-81.
211. Laeijendecker R, van Joost T. Oral manifestations of gold allergy. J Am Acad Dermatol. 1994;30(2 Pt 1):205-9.
212. Nedorost S, Wagman A. Positive patch-test reactions to gold: patients' perception of relevance and the role of titanium dioxide in cosmetics. Dermatitis. 2005;16(2):67-70.
213. Jacob SE, Rouhani P. Focus on allergen of the year 2001: gold. Skin Aging. 2006;16-22.
214. Henriks-Eckerman ML, Suuronen K, Jolanki R. Analysis of allergens in metalworking fluids. Contact Dermatitis. 2008;59(5): 261-7.
215. Warshaw EM, Belsito DV, DeLeo VA, Fowler Jr JF, Maibach HI, Marks JG, Toby Mathias CG, Pratt MD, Rietschel RL, Sasseville D, Storrs FJ, Taylor JS, Zug KA. North American Contact Dermatitis Group patch-test results, 2003-2004 study period. Dermatitis. 2008;19(3):129-36.
216. Bryld LE, Agner T, Menné T. Allergic contact dermatitis from 3-iodo-2-propynyl-butylcarbamate (IPBC) -an update. Contact Dermatitis. 2001;44(5):276-8.
217. Schnuch A, Geier J, Brasch J, Uter W. The preservative iodopropynyl butylcarbamate: frequency of allergic reactions and diagnostic considerations. Contact Dermatitis. 2002;46(3):153-6.
218. Brasch J, Schnuch A, Geier J, Aberer W, Uter W, German Contact Dermatitis Research Group, Information Network of Departments of Dermatology. Iodopropynylbutyl carbamate 0.2 % is suggested for patch testing of patients with eczema possibly related to preservatives. Br J Dermatol. 2004;151(3):608-15.
219. Lanigan RS. Final report on the safety assessment of iodopropynyl butylcarbamate (IPBC). Int J Toxicol. 1998;17(5):1-37.
220. Hasan T, Rantanen T, Alanko K, Harvima RJ, Jolanki R, Kalimo K, et al. Patch test reactions to cosmetic allergens in 1995-1997 and 2000-2002 in Finland-a multicentre study. Contact Dermatitis. 2005;53:40-5.
221. Wakelin SH, Smith H, White IR, Rycroft RJ, McFadden JP. A retrospective analysis of contact allergy to lanolin. Br J Dermatol. 2001;145:28-31.
222. Jacob SE, Ai J. Focus on T.R.U.E. test allergen #2: lanolin-wool wax. Skin Aging. 2005;13(1):25-6.
223. Castanedo-Tardan MP, Jacob SE. Allergic contact dermatitis to sorbitan sesquioleate in children. Contact Dermatitis. 2008;58(3): 171-2.
224. Pratt MD, Belsito DV, DeLeo VA, Fowler Jr JF, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis. 2004;15(1): 25-32.
225. Marks J, et al. MCI/MI (Kathon CG) biocide -United States multicenter study of human skin sensitization. Am J Contact Dermat. 1990;1:157.
226. De Groot AC, Weyland JW. Contact allergy to MDGN in the cosmetics preservative Euxyl K400. Am J Contact Dermat. 1991;2:31-2.
227. Schnuch A, Geier J, Uter W, Frosch PJ. Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study. Br J Dermatol. 1998;138(3):467-76.
228. Nguyen SH, Dang TP, MacPherson C, Maibach HI. Prevalence of patch test results from 1970 to 2002 in a multi-centre population in North America. Contact Dermatitis. 2008;58:101-6.
229. Chambers HF. Aminoglycosides & spectinomycin. In: Katzung BG, editor. Basic and clinical pharmacology. 9th ed. New York: Lange Medical/McGraw-Hill; 2004.
230. Jacob SE, Herrick D. Focus on T.R.U.E. test allergen #3:neomycin. Skin Aging. 2005;13(8):26-8.
231. Spann CT, Tutrone WD, Weinberg JM, Scheinfeld N, Ross B. Topical antibacterial agents for wound care: a primer. Dermatol Surg. 2003;29(6):620-6.
232. Leventhal JS, Berger EM, Brauer JA, Cohen DE. Hypersensitivity reactions to vaccine constituents: a case series and review of the literature. Dermatitis. 2012;23(3):102-9. doi: 10.1097/DER.0b013e31825228cf.
233. Jacob SE, James WD. From road rash to top allergen in a flash: bacitracin. Dermatol Surg. 2004;30:521-4.
234. Agathos M. Anaphylactic reaction to framycetin (neomycin B) and lignocaine. Contact Dermatitis. 1980;6(3):236-7.
235. Veien NK. Ingested food in systemic allergic contact dermatitis. Clin Dermatol. 1997;15:547-55.
236. de Menezes Padua CA, Schnuch A, Lessmann H, Geier J, Pfahlberg A, Uter W. Contact allergy to neomycin sulfate: results of a multifactorial analysis. Pharmacoepidemiol Drug Saf. 2005;14(10): 725-33.
237. Barceloux DG. Nickel. J Toxicol Clin Toxicol. 1999;37(2):239-58. Erratum in: J Toxicol Clin Toxicol 2000;38(7):813.
238. Pratt MD, Belsito DV, DeLeo VA, Fowler Jr JF, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patchtest results, 2001-2002 study period. Dermatitis. 2004;15:176-83.
239. Jacob SE, Amado A. Focus on T.R.U.E. test allergen #1: nickel. Skin Aging. 2005;13(5):21-4.
240. Herro EM, Russell K, Jacob SE. The common presentations of allergic contact dermatitis in children: a guide to diagnosis and management. Pract Dermatol Pediatr. 2010;27-34.
241. Wöhrl S, Jandl T, Stingl G, Kinaciyan T. Mobile telephone as new source for nickel dermatitis. Contact Dermatitis. 2007;56:113.
242. Livideanu C, Giordano-Labadie F, Paul C. Cellular phone addiction and allergic contact dermatitis to nickel. Contact Dermatitis. 2007;57:130-1.
243. Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol. 1993;29(6):1002-7.
244. Arnich N, Sirot V, Riviere G, Jean J, Noel L, Guerin T, Leblanc JC. Dietary exposure to trace elements and health risk assessment in the 2nd French Total Diet Study. Food Chem Toxicol. 2012; 50(7):2432-49.
245. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 672.
246. Dotterud LK, Falk ES. Metal allergy in north Norwegian schoolchildren and its relationship with ear piercing and atopy. Contact Dermatitis. 1994;31:308-13.
247. Nakamura M, Arima Y, Nobuhara S, Miyachi Y. Nickel allergy in a trumpet player. Contact Dermatitis. 1999;40:219-20.
248. Moennich JN, Zirwas M, Jacob SE. Nickel-induced facial dermatitis: adolescents beware of the cell phone. Cutis. 2009;84(4): 199-200.
249. Silvestri DL, Barmettler S. Pruritus ani as a manifestation of systemic contact dermatitis: resolution with dietary nickel restriction. Dermatitis. 2011;22(1):50-5.
250. Hsu JW, Jacob SE. Children's toys as potential sources of nickel exposure. Dermatitis. 2009;20(6):349-50.
251. Veien NK. Systemic contact dermatitis. Int J Dermatol. 2011;50(12):1445-56.
252. Guy et al. Metals and the skin, topical effects and systemic absorption. New York: Marcel Dekker; 1999. p. 307.
253. Neri I, Guareschi E, Savoia F, Patrizi A. Childhood allergic contact dermatitis from henna tattoo. Pediatr Dermatol. 2002;19(6):503-5.
254. Chung WH, Chang YC, Yang LJ, Hung SI, Lin JY, et al. Clinicopathologic features of skin reactions to temporary tattoos and analysis of possible causes. Arch Dermatol. 2002;138(1):88-92.
255. Brancaccio RR, Brown LH, Chang YT, Fogelman JP, Mafong EA, Cohen DE. Identification and quantification of para-phenylenediamine in a temporary black henna tattoo. Am J Contact Dermat. 2002;13:15-8.
256. Sosted H, Johansen JD, Andersen KE, et al. Severe allergic hair dye reactions in 8 children. Contact Dermatitis. 2006;54:87-91.
257. Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, Eichenfield LF. p-Phenylenediamine in black henna tattoos: a practice in need of policy in children. Arch Pediatr Adolesc Med. 2008;162(8):790-2.
258. Leysat SD, Boone M, Blondeel A, Song M. Two cases of cross-sensitivity in subjects allergic to paraphenylenediamine following ingestion of polaronil. Dermatology. 2003;206:379-80.
259. Arroyo MP. Black henna tattoo reaction in a person with sulfonamide and benzocaine allergy. J Am Acad Dermatol. 2003;48(2): 301-2.
260. Geldof BA, Roesyanto ID, van Joost TH. Clinical aspects of paratertiary-butylphenolformaldehyde resin. Contact Dermatitis. 1989;21:312-5.
261. Herro EM, Friedlander SF, Jacob SE. Bra associated allergic contact dermatitis: p-tert-butylphenol formaldehyde resin as the culprit. Pediatr Dermatol. 2012;29(4):540-1.
262. Rietschel R, Fowler JF. Fisher's contact dermatitis. 6th ed. Hamilton: BC Decker Inc; 2008. p. 274-5.
263. Biebl KA, Warshaw EM. Allergic contact dermatitis to cosmetics. Dermatol Clin. 2006;24(2):215-32, vii.
264. Cashman AL, Warshaw EM. Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. Dermatitis. 2005;16(2):57-66; quiz 55-6.
265. Castanedo-Tardan MP, Jacob SE. Potassium dichromate. Dermatitis. 2008;19(4):E24-5.
266. Jacob SE, Amado A. Focus on T.R.U.E. test allergen #4:chromates. Skin Aging. 2005;13(11):21-3.
267. Veien NK, Hattel T, Justesen O, Norholm A. Oral challenge with metal salts. (I). Vesicular patch-test-negative hand eczema. Contact Dermatitis. 1983;9:402-6.
268. Holden CR, Gawkrodger DJ. 10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important? Contact Dermatitis. 2005;53:37-9.
269. Warshaw EM, Schram SE, Belsito DV, DeLeo VA, Fowler Jr JF, Maibach HI, et al. Shoe allergens: retrospective analysis of crosssectional data from the North American contact dermatitis group, 2001-2004. Dermatitis. 2007;18:191-202.
270. Lowther A, McCormick T, Nedorost S. Systemic contact dermatitis from propylene glycol. Dermatitis. 2008;19(2):105-8.
271. Ownby DR. A history of latex allergy. J Allergy Clin Immunol. 2002;110:s27-32.
272. Hosler D, Burkett SL, Tarkanian MJ. Prehistoric polymers: rubber processing in ancient Mesoamerica. Science. 1999;284: 1988-91.
273. Slack C. Noble obsession: Charles Goodyear, Thomas Hancock, and the race to unlock the greatest industrial secret of the nineteenth century. New York: Hyperion; 2003.
274. Jacob SE, Villafradez-Diaz LM. Focus on T.R.U.E. test allergen #15: carbamates. Skin Aging. 2005;13(10):26-30.
275. Cronin E. Shoe dermatitis. Br J Dermatol. 1966;78(12):617-25.
276. Marks J, DeLeo V. Standard allergens. In: Contact and occupational dermatology. 2nd ed. St. Louis: Mosby; 1997. p. 98-102.
277. Jacob SE, Nelson C. Focus on T.R.U.E. test allergen #19 & #22: mercaptobenzothiazole and mercapto mix. Skin Aging. 2006;14(9):19-20, 22, 24, 26.
278. Jacob SE, Dimson O. Focus on T.R.U.E. test allergen #24: thiuram. Skin Aging. 2006;14(2):44, 49-50.
279. Jacob SE, Anderson. Focus on NACDG allergen: mixed dialkyl thioureas. Skin Aging. 2007;15:16-8.
280. Roul S, Ducombs G, Leaute-Labreze C, Taieb A. "Lucky Luke" contact dermatitis due to rubber components of diapers. Contact Dermatitis. 1998;38(6):363-4.
281. Belhadjali H, Giordano-Labadie F, Rance F, Bazex J. "Lucky Luke" contact dermatitis from diapers: a new allergen? Contact Dermatitis. 2001;44(4):248.
282. Jordan WP, Bourlas MC. Allergic contact dermatitis to underwear elastic. Chemically transformed by laundry bleach. Arch Dermatol. 1975;111:593-5.
283. Martensen-Larsen O. Five years' experience with disulfiram in the treatment of alcoholics. Q J Stud Alcohol. 1953;14(3):406-18.
284. Fisher AA. Allergic reactions to nonrubber products by testing with rubber mixes. Part II: the mercapto mix. Cutis. 1995;56:197.
285. Bonnevie P, Marcussen P. Rubber products as a widespread cause of eczema. Report of 80 cases. Acta Derm Venereol. 1944;25:163-78.
286. Castanedo-Tardan MP, Jacob SE. Sorbitan sesquioleate. Dermatitis. 2008;19(4):E22-3.
287. Asarch A, Scheinman PL. Sorbitan sesquioleate, a common emulsifier in topical corticosteroids, is an important contact allergen. Dermatitis. 2008;19(6):323-7.
288. Jacob SE, Huo R. Focus on T.R.U.E. test allergen #23: thimerosal. Skin Aging. 2006;14:16-18, 21.
289. Engler DE. Mercury "bleaching" creams. J Am Acad Dermatol. 2005;52(6):1113-4.
290. Breithaupt A, Jacob SE. Thimerosal and the relevance of patch-test reactions in children. Dermatitis. 2008;19(5):275-7.
291. Tsuruta D, Sowa J, Higashi N, Kobayashi H, Ishii M. A red tattoo and a swordfish supper. Lancet. 2004;364(9435):730.
292. Fisher AA. Contact dermatitis. 3rd ed. Philadelphia: Lea & Febiger; 1986 p. 383-4.
293. Elder RL. Final report on the safety assessment of toluenesulfonamide/ formaldehyde resin. Int J Toxicol. 1986;5(5):471-90.
294. Stechschulte SA, Avashia N, Jacob SE. Tosylamide formaldehyde resin. Dermatitis. 2008;19(3):E18-9.